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Abstract
The domestic dog, Canis familiaris, is a well-established model system for mapping trait and disease loci. While the original
draft sequence was of good quality, gaps were abundant particularly in promoter regions of the genome, negatively
impacting the annotation and study of candidate genes. Here, we present an improved genome build, canFam3.1, which
includes 85 MB of novel sequence and now covers 99.8% of the euchromatic portion of the genome. We also present
multiple RNA-Sequencing data sets from 10 different canine tissues to catalog ,175,000 expressed loci. While about 90% of
the coding genes previously annotated by EnsEMBL have measurable expression in at least one sample, the number of
transcript isoforms detected by our data expands the EnsEMBL annotations by a factor of four. Syntenic comparison with
the human genome revealed an additional ,3,000 loci that are characterized as protein coding in human and were also
expressed in the dog, suggesting that those were previously not annotated in the EnsEMBL canine gene set. In addition to
,20,700 high-confidence protein coding loci, we found ,4,600 antisense transcripts overlapping exons of protein coding
genes, ,7,200 intergenic multi-exon transcripts without coding potential, likely candidates for long intergenic non-coding
RNAs (lincRNAs) and ,11,000 transcripts were reported by two different library construction methods but did not fit any of
the above categories. Of the lincRNAs, about 6,000 have no annotated orthologs in human or mouse. Functional analysis of
two novel transcripts with shRNA in a mouse kidney cell line altered cell morphology and motility. All in all, we provide a
much-improved annotation of the canine genome and suggest regulatory functions for several of the novel non-coding
transcripts.
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Introduction
The dog, Canis familiaris, is an important and well-established
genetic model used to study human disease. Since dogs were first
domesticated more than 10,000 years ago [1–4], they have shared
their immediate surroundings with humans, and as a consequence
have been exposed to many of the same pathological, dietary [1]
and environmental conditions. In only a few centuries, hundreds
of dog breeds have been created and continuously selected to
generate diverse morphological, physiological and behavioral
variation. However, an unintended side effect to this process has
also led to the accumulation of certain health disorders within
specific breeds. In 2005, the first high-quality draft genome was
published accompanied by a SNP discovery effort and the
characterization of haplotype structure, as well as power
calculations for strategies for genome-wide association mapping
of trait and disease loci [5]. Intense breeding has resulted in short
linkage disequilibrium (LD) across breeds but long LD within
breeds, thus making the pure bred dog an ideal model to study
disorders that also affect humans through genome wide association
[5,6].
Multiple SNP arrays were designed based on the canine draft
genome assembly and these were effectively used to map by
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genome-wide association (GWAS) some of the phenotypically
plastic traits under selection, including coat color [7,8] and
morphology [9–11]. Whilst those studies offered insight into basic
biology (pigmentation, bone formation), parallel investigations into
specific heritable diseases suffered by humans and their canine
companions revealed novel pathways (NFAT in SLE-like disease
[12], HAS2 biosynthesis in autoinflammatory disease [13]) and
candidate genes for disease biology such as LGI2 in remitting focal
epilepsy [14], and SLC4A3 in progressive retinal atrophy [15]. The
mutations identified to date include both changes in proteins, as
well as alterations in gene expression regulation.
While GWAS is relatively effective in dogs, the identification of
actual mutations has been more difficult for several reasons. First,
there are many gaps in the draft genome caused by sequencing
bias against GC-rich regions, particularly in promoters and first
exons. It has been proposed that the high GC content may have
been caused by the loss of PRDM9 in the canine lineage, in turn
leading to sustained recombination hotspots and GC biased gene
conversion in these regions [16]. Secondly, a comprehensive
catalog of genes, non-coding transcripts, and regulatory elements
is currently not available, a resource that would be greatly
beneficial when identifying the causal mutations of complex
diseases, many of which are likely regulatory in nature. For
example, expression levels of immunoglobulin E antibodies have
been linked to allergic reactions, and while two GWAS signals
have been found [17], no obvious gene candidates were annotated
in these regions. This, among other examples, highlights how the
potential of mutation identification is limited by the quality of the
genome, as well as the set of transcribed and characterized
features.
Here, we sought to improve the assembly quality and
completeness, as well as transcript annotation for both coding
and non-coding genes. We first present canFam3.1, a new genome
build in which thousands of gaps were filled. In addition, we
present a new annotation, which greatly expands the repertoire of
known dog transcripts, including protein coding genes, putative
long intergenic non-coding RNAs (lincRNAs), and antisense
transcripts. This resource will now be available to the genetics
community (http://genome.ucsc.edu/cgi-bin/hgHubConnect
‘‘Broad Improved Canine Annotation v1’’).
Results
Improved quality and contiguity of the canine genome
Despite the overall high quality of the dog canFam2.0 assembly,
,1% of the euchromatic genome resides in gaps and ,0.5% of
the assembly shows evidence of potential assembly errors. In
addition, ,20% of genes show some evidence of sequencing
errors, such as frameshifts, very short introns, and missing first
exons and promoters. To improve the quality and completeness of
the canine genome sequence, we targeted the following regions: (a)
small assembly gaps, many of which are caused by either simple
sequence repeats, or cloning bias against high GC content; and (b)
long-range assembly gaps or errors that are likely part of any draft
genome produced from whole-genome shotgun sequencing [18],
predominantly caused by transposable elements and segmental
duplications. For closing small gaps, we employed 12,101 primer
walks (see Methods), while we used re-sequencing of Bacterial
Artificial Chromosomes (BACs) to close large gaps and cover mis-
assembled regions. For BAC re-sequencing, we selected (a) 283
gaps larger than 35 kb; (b) 100 clusters of gaps less than the BAC
size of 180 kb; (c) 22 gaps between adjacent scaffolds anchored to
the same chromosome; (d) 59 centromeric and telomeric regions;
and (e) 65 regions indicated as being problematic by the whole
genome shotgun assembler Arachne [19] which were of $50 kb,
or which fell close to a gap of size 10–35 kb. This totaled 149
BACs. In addition, we picked 186 BACs to cover the dog
homologs to the 45 human ENCODE pilot regions [20]. In total
we integrated 85 Mb (an ,0.4% increase) of novel sequence from
BAC and primer walks into the canFam2.0 assembly to create
canFam3.1 (see Methods, integration of improved sequences). The
new assembly version has 14,418 gaps, 95% of which are less than
2 kb, while the amount of sequence currently flagged as potentially
mis-assembled is less than 0.2% (4.1 Mb) of the assembly (Table 1).
The new genome build closed a total of 1,044 gaps containing
promoters and/or first exons of protein coding genes that were
missing in canFam2.0.
Generating a transcriptome
We performed deep RNA sequencing (RNA-Seq) to generate a
comprehensive catalogue of transcripts for the dog genome, to
both augment the set of known protein coding genes, as well as to
denote and characterize non-coding transcripts that have previ-
ously not been listed in the EnsEMBL annotation. We used ten
different dog tissues: blood, brain, heart, kidney, liver, lung, ovary,
skeletal muscle, skin, and testis (Table S1) to create two sets of
libraries: (a) strand-specific dUTP with poly-A selection [21],
which specifically captures protein coding genes and other
transcripts transcribed by polymerase II by targeting the poly-
adenylated transcript tails; and (b) duplex-specific nuclease (DSN),
which substantially reduces the levels of the highly abundant
ribosomal transcripts through normalization, and does not depend
on the mechanism of transcription [22]. We sequenced each
sample using the Illumina HiSeq platform, generating between 30
and 100 million paired-end reads of 101 bp each. We mapped all
reads from the resulting 21 libraries (brain and kidney were
generated in duplicates for poly-A, and the DSN skin library was
excluded due to poor alignment performance) to the canFam3.1
genome build using the splice junction mapper Tophat (version
2.0.5) [23] (Table S1), and assembled transcript models using the
Cufflinks package (version 2.0.2) [24] without guidance from any
existing annotation.
Overall, we identified 65,314 loci from all poly-A selected
samples combined, with testis showing the highest number of
expressed loci (41,070 loci, Table 2). This agrees with previous
observations showing that polymerase II activity is elevated in the
germ-line [25]. The overlap of expressed loci between any two
tissues sequenced from the poly-A libraries varied from 50% to
90% depending on the pair-wise tissue comparison (Table S2-A).
The mean transcript size was 3169 bp (median 2173 bp). Related
tissues such as skeletal muscle and heart shared the largest number
of loci (88.4%). In contrast, the DSN libraries revealed a
substantially larger number of total loci (194,878) ranging from
33,857 in testis to 96,231 in liver (Table S2-B), but the transcripts
had a smaller mean transcript size of 1485 bp (median 809 bp).
The combined set of poly-A and DSN data resulted in 249,889
transcripts contained in 174,336 loci. Of these, 99,468 (57%) loci
containing 150,034 transcripts showed a measurable (FPKM.0.1)
expression in both library preparation types.
In the following sections, we categorize the transcripts, both
through comparison with known features in dog and human, as
well as by their genomic locations, splicing, and expression
patterns.
An extended catalog of protein coding genes
The products of protein-coding genes, which are transcribed by
polymerase II, constitute the most well-characterized fundamental
building blocks of life. Out of the 19,856 loci that are annotated by
CanFam3.1 and Annotation
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EnsEMBL (build 64) as such in the canine genome, 17,715 (89%)
showed measurable expression (FPKM.0.1, i.e. .1-fold physical
read coverage) in at least one sample and one library construction
method in our data set. About 76% of loci were reported by both
poly-A and DSN, 20% by poly-A only, while only 3.1% were
detected by DSN but not poly-A. To recover protein-coding genes
missed by the dog EnsEMBL annotation, we syntenically mapped
all protein coding genes from the human genome (Hg19,
EnsEMBL 68) to canFam3.1 using the synteny aligner Satsuma
[26] and the coordinate mapper RUM (Zamani et al., submitted).
We found an additional 2,942 loci supported by our RNA-Seq
data in which protein coding annotations existed in the human
orthologous regions, bringing the total number of ‘high-confidence
protein coding genes’ to 20,657, which is comparable to the
21,329 annotated protein coding genes in the human genome
(Table S3). Moreover, RNA-Seq estimated an average of 4.7
alternative isoforms per locus, which is similar to human and
mouse annotations in EnsEMBL [27], and much higher than the
1.27 isoforms per dog gene as annotated by EnsEMBL. However,
the number is still smaller than the 10–12 isoforms per cell line
that have been observed [28] through much deeper sequencing of
RNA. A total of 2,141 EnsEMBL protein-coding genes (2,741
transcripts) did not have any measurable support in the RNA-Seq
data. Since it is possible that at least a fraction of these genes are
correct predictions, but were not detectable in the data, as they
could be expressed in a very tissue-specific manner (e.g. olfactory
receptors), or only during early developmental stages, we included
these loci in the list of protein coding genes, totaling 22,798 loci.
A wealth of antisense transcripts
Antisense transcription has been reported to facilitate a more
fine-tuned regulation of gene expression, usually of the protein
coding gene located sense to the antisense element [29,30]. In our
RNA-Seq data set, we found 4,636 sequences that were
transcribed from the opposite strand of a protein-coding gene
and which also overlapped with at least one sense exon. More than
half of the transcripts (2,379, 51.3%) featured multiple exons.
Antisense transcripts showed more tissue-specific patterns com-
pared to protein coding genes, with only 15 antisense loci being
expressed in all samples and tissues (FPKM.0.1) and 994 (21.4%)
specific to a single tissue. To determine whether antisense
transcripts are associated with tissue-specific cellular processes,
we analyzed their protein coding host genes using the Ingenuity
Pathway Analysis package (Ingenuity Systems, http://www.
ingenuity.com). The analysis revealed a diverse range of gene
functions and many generic networks, such as ‘DNA replication
and repair’ (39 molecules), ‘post-translational modification’ (37
molecules), and ‘nervous system development’ (37 molecules)
(Table S4). The most prominent canonical pathway is ‘protein
kinase A signaling’ (p,2.761024) and ‘other cell-to-cell commu-
nication pathways’ (p,361023, Table S5). These findings would
suggest that the cellular processes subject to antisense regulation
were ubiquitous and not associated with networks particular to any
tissue type, but rather that the tissue-specific antisense expression
patterns could be utilized to fine-tune these basic processes in
different cell types and cell states.
Long intergenic non-coding transcripts
Thousands of long intergenic non-coding transcripts (lincRNAs)
have been identified in the human and mouse genomes in the past
few years, but the function has only been defined for a small
subset, which are involved in the modulation of gene expression
[31], imprinting [32,33], and embryonic development [34]. Here
we define canine lincRNAs as transcripts that (a) have no
recognizable protein coding potential (see Methods); (b) do not
overlap with either high- or low-confidence protein coding genes;
and (c) have a spliced multi-exon structure. We found a total of
7,224 intergenic transcripts that fit these criteria (between 2 and 15
exons), and of these, 5,916 had not previously been annotated in
either dog or human (see Methods). The mean transcript size was
1,894 bp (median 1,129 bp) and the mean span on the genome
19.3 kb (median 7.7 kb). Similar to protein coding genes, their
distribution is uneven across the genome and differs between
tissues, as exemplified by their locations on dog chromosome 1
(Figure 1A).
In line with previous findings [35], lincRNAs appeared to be
highly tissue specific, with 37% of transcripts showing single tissue
expression (tau= 1) [36]). The average tau score was 0.96 for
lincRNAs as compared to 0.82 for protein-coding genes and 0.90
for antisense transcripts. Neighboring protein-coding genes are
enriched for canonical pathways involved in development and
differentiation (Wnt/b-catenin Signaling 3.361026, Factors
Table 1. Comparison of canFam2.0 and canFam3.1.
Property canFam2.0 canFam3.1
Coverage of euchromatic portion of genome (%) 99.2 99.6
Portion of assembly in ‘‘certified regions’’ (%) 99.5 99.8
Contiguity: gaps per Mb 12 6
ENCODE regions High-quality draft 98% Finished
doi:10.1371/journal.pone.0091172.t001
Table 2. Transcribed loci per tissue and library preparation.
Brain Blood Heart Kidney Liver Lung Muscle Ovary Skin Testis Total
Poly-A 30,325 33,486 23,807 28,420 25,431 29,493 39,976 22,221 34,335 41,070 65,314
DSN 69,030 64,657 43,659 38,059 96,231 67,842 31,006 83,665 N/A 33,857 194,878
N/A, due to poor alignment performance, this library was excluded from subsequent analyses.
doi:10.1371/journal.pone.0091172.t002
CanFam3.1 and Annotation
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Promoting Cardiogenesis in Vertebrates 1.361024, Mouse Em-
bryonic Stem Cell Pluripotency 2.761024, Human Embryonic
Stem Cell Pluripotency 4.561025) agreeing with previous studies
[35,37], but also for genes regulating the immune-system (Role of
Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid
Arthritis 2.561025, see Table S6).
Other non-coding transcripts
In contrast to protein coding genes, antisense transcripts and
long intergenic non-coding RNAs, there is little systematic
knowledge about transcribed loci that do not fit into any of these
categories. The dog EnsEMBL annotation lists 4,724 such loci as
non-coding, with an additional 12,736 loci having orthologs
annotated as microRNAs, snoRNAs, pseudogenes, etc. in the
human EnsEMBL annotation. Out of those, only 1,818 (931 dog,
887 human orthologs) showed expression at FPKM.0.1 in the
RNA-Seq data set generated here. By contrast, we found 137,996
transcripts expressed above that threshold that have not previously
been described before in the dog or human genome. In terms of
genomic location, the largest category is comprised of intronic
transcripts on the same strand as their spliced coding (92,657 loci,
67.1%) and non-coding (3,735 loci, 2.7%) host genes, suggesting
that these transcripts are artifacts of incompletely processed
introns. We note that 65% of these loci were reported by both
library construction methods, 33% by DSN only, and that the
poly-A fraction is an almost perfect subset of the DSN sequences
with only 1.8% of loci being detected by poly-A but not DSN. This
finding would be consistent with the poly-A protocol also targeting
incompletely spliced intronic sequences that are rich in the
nucleotide adenosine. An additional 6,908 transcripts are located
in introns of protein coding genes but in the antisense direction.
Unlike intronic sense transcripts, only 0.05% of which are spliced,
,30% of intronic antisense sequences feature multiple exons,
suggesting that these transcripts might be unconnected fragments
of antisense transcripts as described above or potentially unchar-
acterized unique transcripts.
Of the remaining 41,584 single-exon transcripts located in
intergenic regions that were reported by the RNA-Seq data but
not supported by known features, we found a fraction that were
located in close proximity to known genes, including (a) 9,775 loci
located on the same strand as the nearest genes and within 25 kb
downstream of its 39 transcription stop site, noting that these could
be the by-product of spurious transcription beyond the stop site
(mean expression: FPKM 2.4); and (b) 2,961 loci on the reverse
strand to the nearest protein coding genes and within 5 kb region
upstream of the transcription start, perhaps the result of promoter
bi-directional activity (mean expression: FPKM 2.3). However, the
majority of intergenic transcripts (28,868, or 69.4%) are not
strongly co-located with protein coding genes (mean distance
150 kb in both the 59 and 39 direction (Figure 1B)). This agrees
with previous findings that in general, non-coding RNAs are not
strongly co-located with protein coding genes [38], but also that
these transcripts might be actively and independently transcribed,
rather than being the byproduct of nearby protein coding gene
transcription. However, we note that only 38% of these loci are
reported by both library construction methods, with 32.1%
detected by DSN only, and 26.4% by poly-A only, thus we
cannot rule out that a fraction of these intergenic transcripts could
be artifacts originating from genomic DNA.
Distinct expression patterns for coding, antisense,
lincRNA, and intergenic loci
An examination of gene expression patterns within and across
tissues may indicate potential biological roles for different
transcript types. Overall, protein coding genes are more highly
expressed than non-coding transcripts: at the 95th percentile of
expression, protein coding genes show an FPKM value of 48.0,
while intergenic non-coding loci exhibit 10-fold lower levels
(FPKM=5.6), and antisense loci being transcribed at even lower
levels (FPKM=3.2) (Figure S1). Neighbor-joining (NJ) phylogenies
(Figure 2) were drawn to investigate trends in expression patterns
for each class of molecule and each library type (poly-A, blue;
DSN, red). The distance between two samples was calculated as
one minus Spearman’s rank correlation coefficient (rho), based on
FPKM values (methods). The NJ tree groups protein coding genes
(Figure 2a) first by tissue, whereas a tree computed from antisense
transcripts (Figure 2b) grouped samples by library construction
first, with testis being the only exception. Expression of spliced
lincRNAs (Figure 2c) resembles the pattern of protein-coding
genes, indicating tissue specificity comparable to protein coding
Figure 1. Location of lincRNAs and single-exon intergenic non-coding transcripts. (a) We show the mapping of lincRNAs, broken down by
sample across chromosome 1. (b) Histogram of distance from intergenic transcripts to the next known transcribed element in both the 59 (left) and 39
(right) direction. The average distance is around 150,000 nucleotides, suggesting that these loci are not closely associated with known genes.
doi:10.1371/journal.pone.0091172.g001
CanFam3.1 and Annotation
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genes, even though lincRNAs are expressed at lower levels overall.
By contrast, the unspliced ,41,000 intergenic RNAs (Figure 2d)
follow a pattern similar to antisense transcripts. Altogether this
implicates intriguing differences in regulation of expression by
protein-coding genes and lincRNAs versus antisense transcripts
and single exon intergenic transcripts.
Validation of non-coding RNA loci
In order to validate the novel non-coding RNA transcripts we
selected 13 intergenic and 9 antisense loci, which were primarily
expressed in one tissue at a FPKM.1, and performed quantitative
RT-PCR in a panel of 10 tissues from up to 4 different dogs (24
samples total: brain, either cerebellum or cortex; gonad, ovary or
testis; heart; kidney; liver; lung; pancreas; skin, see Methods). All
22 transcripts except one (96%) were detected in the discovery
tissue, although seven transcripts (32%, primarily those discovered
in brain and gonads) were not detected in all samples of that
particular tissue, suggesting that expression may be regulated by
region or cell state within the tissue (Tables S7, S8). Curiously, all
transcripts also showed expression, often at low levels, in one or
more other tissue, supporting the notion that these transcripts may
be active in tissues other then the one in which they were
discovered. This may also indicate a sample specificity stemming
from temporal changes in expression, or the different conditions in
which the samples were collected. Nonetheless, these data solidly
support the expression of these transcripts, consistent with the
potential for biological function.
Figure 2. Distance trees of expression profiles. We constructed neighbor-joining trees based on the correlation between expression values
(FPKM.1.0) between samples, with 1 minus Spearman’s rho defining the distance. Colors denote library construction methods (poly-A: blue, DSN:
red). We divided transcribed loci into (a) protein coding genes with RNA-Seq support, either annotated by EnsEMBL in dog or EnsEMBL in the human
orthologous regions. Replicates cluster together, so do the library constructions methods poly-A and DSN, as well as related tissues, such as heart and
muscle; (b) antisense transcripts, that overlap at least one exon of a protein coding gene, as defined in (a). With the exception of testis, poly-A and
DSN separate the samples, with both the poly-A and DSN sub-trees maintaining closer relationships between the related tissues heart and muscle; (c)
spliced intergenic loci, excluding sequences that have coding potential. Similar to protein coding genes, the poly-A and DSN group by tissue first,
with the exception of kidney DSN; and (d) intergenic and uncharacterized single-exon transcript loci. In this set, DSN and poly-A are, similar to
antisense loci, the most dominant factor when grouping samples.
doi:10.1371/journal.pone.0091172.g002
CanFam3.1 and Annotation
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Cross-species functional analysis of novel non-coding
kidney specific transcripts
The canine multi-tissue RNA-seq data presented here are
consistent with results from other species, in that they suggest a
multitude of non-coding RNA sequences to be actively transcribed
[28]. To test whether orthologous sequences are also transcribed
in other species, mouse and human, we selected nine multi-exonic
canine transcripts, seven antisense and two lincRNAs, previously
not seen in human or mouse. The transcripts were expressed in
kidney in our RNA-Seq data and were therefore amplified in dog
kidney as well as in mouse and human kidney RNA by RT-PCR,
using primers from orthologous regions (see methods). Six of the
seven antisense multi-exon canine loci expressed in canine kidney
were amplified from human kidney RNA and both lincRNAs were
also present in human and mouse kidney RNA (Table S9).
To assess the potential function of a subset of novel transcripts,
we chose two novel spliced non-coding RNAs (one antisense and
one lincRNA) based on their location near Baiap2, a gene for
which the effect of its expression level has previously been
described in a murine podocyte cell model [39]. Baiap2 is essential
for filapodia formation, actin cytoskeleton formation/stability, and
for the motility of kidney podocytes (part of the glomerulus in the
kidney). It has been shown that the over-expression of Baiap2
increased filapodia formation, while gene knockdown resulted in
decreased murine podocyte migration as assessed by wound
healing assay [39]. We designed multiple shRNAs for the antisense
intronic transcript (located in intron 5), and the lincRNA located
at the 59 end of the gene, ,10 kb away. Podocytes were infected
with snRNA containing lentivirus and cell migration (wound
healing) was measured at 48 hours. As expected [39], shRNAs
targeting the coding region of Baiap2 resulted in decreased
migration. shRNAs directed against the lincRNA resulted in a
further reduction in podocyte migration and alteration of the actin
cytoskeleton (Figure 3), whilst increased filapodia formation and
increased podocyte migration were observed with shRNAs
directed against the intronic antisense transcript. Quantitative
PCR confirmed reduced expression of Baiap2 in podocytes treated
with shRNAs to the coding region and the lincRNA, but
unchanged expression in podocytes treated with shRNAs to the
antisense transcript (Figure S2). Further studies are required to
determine if these transcripts have cis effects at the Baiap2 locus, or
if they perform a more global modulation of podocyte gene
expression.
Discussion
The dog genome is important both for mammalian comparative
sequence analyses and for use as a model for disease trait mapping
[40,41]. Identifying the underlying genomic causes for disease
susceptibility at high resolution requires both a high quality
genome sequence, as well as a comprehensive catalogue of
transcribed features and regulatory elements. Here, we present an
improved genome build, canFam3.1, together with a comprehen-
sive annotation of protein coding and non-coding genes. Through
deep sequencing of RNA obtained from ten different tissues, we
significantly expanded the set of protein coding genes, both in
terms of the number of loci and in alternative isoforms per gene,
with the latter representing a four-fold increase of that previously
listed by EnsEMBL.
It is well accepted that variants that alter amino acid sequences,
introduce frame shifts and/or premature stop codons can deleteri-
ously affect protein and cellular function. However, more and more
data suggest that regulatory mutations are perhaps more important
for understanding complex human diseases. It is therefore
paramount to pinpoint mutations that affect the regulatory
machinery, including regulatory transcripts of different types.
Antisense transcripts, which overlap with protein coding genes,
frequently regulate their host genes, and we now annotate
thousands of such loci in the dog genome for the first time.
Likewise, transcribed and spliced, but non-protein-coding tran-
scripts, termed lincRNAs, constitute a putative class of transcripts
that have been linked to modulation of gene expression [31],
imprinting [31–34,42], or protein scaffolding [37,43]. While none
have previously been reported in the dog genome, we now list the
locations of more than 7,000 lincRNAs, of which only a little over a
thousand have previously annotated orthologous counterparts in
the human genome. Interestingly, we found that, unlike antisense
transcripts, the expression patterns of lincRNAs more closely
resemble those of protein coding genes, indicating that the implied
‘regulatory roles’ of lincRNAs and antisense transcripts might be
fundamentally different; this notion is further supported by GO
term analysis of the host genes of antisense loci, which suggests that
these transcripts are, at least in part, involved in the regulation of
fundamental cellular processes common to cells of different tissue
types, whereas the lincRNAs often regulate development and
differenciation as well as cells involved in immune processes.
The biological function of the over 100,000 additional loci that
are reported as transcribed by RNA-Sequence data is even less
clear. Since the majority are located in introns of known genes and
transcribed in the same sense, we interpret these loci as potential
byproducts of incomplete splicing, although the distinct patterns
formed by these transcript may nonetheless signify something.
However, more than 40,000 transcripts are located outside of
known features, and their distribution throughout the genome
would suggest that the majority are independently transcribed,
rather than being run-off products of e.g. protein coding loci. While
their expression patterns retain some weak component of tissue-
specificity, these loci are often more lowly expressed and can vary
between samples, suggesting an involvement in cell state regulation.
In order to further characterize the biological roles and relevance of
these transcripts, comprehensive and systematic knock-down
experiments are required, a low-throughput template of which we
demonstrated using a murine podocyte model. The podocyte
experiments show that two novel non-coding transcripts, one
lincRNA and one antisense, selected because of their proximity to a
gene, Baiap2, important for formation of podocyte filapodia, appear
to regulate this gene and change podocyte morphology and motility
in cell culture. This hints at the regulatory potential and the need to
characterize the function of the thousands of novel non-coding
transcript described in this paper.
In conclusion, we expect that the data set we generated,
analyzed, and presented here will serve as an invaluable genomic
tool to unravel the biology which underscores many diseases; not
just of dogs, but for their masters as well.
The data is freely available from http://genome.ucsc.edu/cgi-
bin/hgHubConnect ‘‘Broad Canine’’. For a detailed description of
putative functional characterization of the transcripts, see Table
S10.
Methods
Ethics statement
A tissue panel (brain, heart, kidney, liver, lung, pancreas, ovary,
skin, testis) was created from 23 samples donated from four
anonymous euthanized dogs following owner consent and ethical
approval. Ethical approval was granted by Uppsala Djurfo¨rso¨kse-
tiska Na¨mnd (Permit Number: C 2/12).
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WGA segment finishing
Finishing targets not represented by BACs were addressed by
directly finishing whole genome assembly (WGA) segments. The
target sequence with an additional ,40 kb on either side was
extracted from canFam2.0, viewed in the genome assembler GAP4
[44], and finished with a combination of fosmid primer walks, PCR
and the incorporation of previously unplaced whole genome
sequencing (WGS) reads. At sites of SNP haplotype difference, the
allele of higher sequence quality was represented. In addition, the
longer sequence was represented for indel polymorphisms.
Automated primer walks of small gaps
After target gaps were identified in the assembly, we identified
those that were covered by at least two fosmid templates. Gaps
that met this coverage requirement were analyzed with primer3
[45,46] to find suitable paired primers. Finishing reads (see below)
were then generated using primer walks and integrated into a
‘‘chunked’’ sub-assembly. The sub-assembly ‘‘chunk’’ is an
approximately 2 kb blunt-end extract of the whole genome
assembly surrounding each gap. This integration was done using
the shotgun assembly module of GAP4. After all finishing reads
were integrated into the chunk assembly, analysis using a novel
data structure called a ‘‘read coverage signature’’ (RCS) was
completed to determine gap closure or extension and to ensure
that the chunk had not been misassembled (see explanation
below). The consensus sequence from the chunks that satisfied the
RCS analysis was subsequently patched into the whole genome
assembly at the positions defined when the chunk was created.
Read coverage signature
A read coverage signature (RCS) is a data structure that serves
as a landmark for cross-assembly navigation. It is constructed by
iterating over each read that covers a consensus base in the
assembly and hashing the read name, the position in the read, and
the base call in the read. A catalog of RCSs can be computed for
an entire assembly or for subsections of an assembly. After these
catalogs are computed, an area of interest in one assembly can be
found in another assembly which shares the same reads by
comparing the RCSs.
Generation of finishing reads from autowalks
Automated primer reads were generated with BigDye and GB
(1:4 dGTP:BigDye, Life Technologies) sequencing chemistries.
Even though the dog genome has GC content similar to the human
genome [5], hard GC stops (i.e. regions high in GC cannot be
accurately sequenced) are relatively frequent. Several sequencing
chemistries and additives were used to address this issue. DMSO
(Dimethyl sulfoxide) was added to our GB chemistry with favorable
Figure 3. Modulation of podocyte motility through shRNAs to non-coding RNAs at the BAIAP2 locus. A) The number of cells (average +/
2 SEM) that migrated into the scratch after 48 hours for each of the four conditions: scrambled shRNAs (negative control), shRNAs directed at coding
sequence (positive control), antisense shRNAs, and lincRNA shRNAs. As previously shown, shRNA to Baiap2 (coding shRNA) inhibited podocyte
migration (p,0.01). shRNAs to the lincRNA further reduced podocyte migration (p,0.001 compared to scrambled shRNA, p,0.01 compared to
coding shRNA), while shRNAs to the antisense transcript resulted in increased podocyte motility (p,0.01). (B–D) Phalloidin (actin) stained podocytes
treated with B) scrambled shRNAs (normal podocyte appearance), C) antisense shRNAs and D) lincRNA shRNAs. Treatment with shRNAs to the
antisense (C) resulted in increased filapodia formation (white arrows), consistent with increased BAIAP2 activity. Treatment with lincRNA shRNAs (D)
resulted in an abnormal appearance of the podocytes and the actin cytoskeleton.
doi:10.1371/journal.pone.0091172.g003
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results. For sequences with 70%–80% GC content, we observed a
14-point increase in Phred quality score with the use of 5% DMSO.
There was a 7-point increase in Phred quality scores for sequences
with 80%–95% GC content as well, and an approximately 50 base
increase in Q20, Q30, and Q40 read lengths.
We also observed a marginal improvement over the DMSO/
GB mix through the use of Resolver (General Electric) template
generation. Some GC stops were recalcitrant to these approaches.
57 clones were submitted as comparative grade finished to avoid
extreme efforts to resolve small stretches of GC rich sequence.
Most gaps in these clones were closed.
Work region integration
Regions where finishing targets (BACs and WGA segments)
overlapped were designated as work regions, which could then be
considered as single units of sequence for patching into the
canFam3.1 assembly. The constituent clones and WGA segments
were integrated using artificial reads generated from the finished
consensus. Rules similar to those employed for finishing WGA
segments were used to address haplotype variation. Completed
multi-BAC assemblies were patched into the original canFam2.0
whole genome assembly, replacing the pre-existing sequence.
Integration of improved sequence
Larger regions of interest that underwent manual finishing, such
as BACs and work regions (see above), are treated similar to the
autowalk ‘‘chunks’’ (see previous) in terms of patching. Their
coordinates from a golden path (AGP) defined a whole genome
‘‘chunk’’, which became a finishing project. When the chunk is
finished, its consensus sequence is patched into the whole genome
assembly at the positions defined when the chunk was created.
RNA sequencing (RNA-Seq)
In total, 22 sequencing libraries were generated from commer-
cially sought RNA (blood, brain, heart, kidney, liver, lung, ovary,
skeletal muscle, skin, and testis (Zyagen)). Each tissue type was
used to generate both a strand-specific poly-A selection library
(n = 10) and a duplex-specific nuclease library (DSN; n= 10). Two
additional poly-A biological libraries were generated (kidney and
brain) to act as biological replicates and to test the robustness of
tissue specific transcript predictions. The poly-A selection protocol
was used to cover sequences transcribed by polymerase II, whilst
the DSN non-selective normalization technique was used to
reduce highly abundant transcripts. The latter was so that we
could sequence all samples comprehensively, but at lower coverage
per locus. All 22 libraries were sequenced on the Illumina
platform, using paired-end reads with an insert size of ,300-600
nucleotides and a strand-specific protocol (dUTP).
Cross-species comparison pipeline
We mapped annotations from the human genome (Gencode
version 9) [47] onto the new genome build using syntenic
relationships between the two genomes in a two-step pipeline
(Zamani et al. submitted). First, we used the synteny aligner
Satsuma [26] to establish syntenic relationships between the
human and dog genome sequences. This information was then
used to produce a rough mapping of annotated features from the
query species to the target species within the syntenic regions.
Candidate mappings were subsequently re-aligned using a local
alignment strategy between feature boundaries. In a final step, we
checked the intron-exon boundaries annotated in this manner for
neighboring canonical splice sites and adjusted accordingly if such
features were found within 5 nucleotides from the predicted
boundaries. While all sequences mapped to canFam2.0 could also
be located in canFam3.1, we note that there were 75 transcripts
that could be mapped from human onto canFam3.1 due to the
recovered sequences, but absent in the canFam2.0 build. Out of
the ,1,000 additional exons in canFam3.1, about 60% are first
exons, regions that are known to be rich in GC content and were
therefore absent from canFam2.0. Of the ,18,300 loci that could
not be mapped from human due to a lack of orthology, the most
prominent group consists of retrotransposed pseudogenes (5,827),
followed by uncharacterized novel genes with unconfirmed
transcriptional support level (4,134). Together these groups
account for more than half of the unmapped gene loci. Gene
families with missing members include olfactory receptors (330),
immunoglobulin and immunoglobulin -related genes (306), zinc
finger proteins (204), microRNAs (209), uncharacterized gene
families (143), and keratins and keratin-associated proteins (103).
RNA-Seq pipeline
We aligned all RNA-Seq reads against the unmasked,
euchromatic portion of the dog reference genome (canFam3.1,
obtained from EnsEMBL release 68) using the splice-junction
mapper Tophat (version 2.0.5) [23] with default parameters. We
filtered the resulting read alignments using a quality cut-off of 15
and assembled them into transcript models individually per tissue
using the cufflinks package (version 2.0.2) [24]. We performed
both steps without a reference annotation to avoid the introduc-
tion of biases. We then merged the transcriptome annotations
from all tissues using the cuffmerge tool - as part of the cufflinks
package - into one consensus annotation for each library
preparation and then into one combined annotation across all
samples (poly-A and DSN).
Expanded feature map for canFam3.1
In order to produce a ‘master’ annotation for the new genome
build, we combined information from the existing annotation with
transcript predictions based on RNA-Seq data (see above). To this
end, we merged the unguided cufflinks consensus models (see above)
with the existing reference annotation (EnsEMBL release 68) using
cuffmerge, as discussed above. The EnsEMBL annotation served as
a reference (option -g) to allow us a better classification of transcript
models obtained from RNA-Seq compared to established gene
models and to identify novel isoforms and loci previously unknown
to be expressed. Novel loci that nevertheless had a correspondence
in human based on synteny (see above) were marked as such,
allowing us to effectively differentiate between reference annota-
tions, novel annotations with human orthologs as well as genuinely
novel dog annotations. In order to make the annotation compact,
we removed 55,149 intronic sense transcripts that are likely by-
products of immature splicing, retaining a total of 194,740
transcripts and 106,079 expressed loci. The data is available as a
color-coded BED file, which also contains expression values for each
tissue and transcript.
Comparing transcripts and loci
A locus is defined as the set of transcripts that overlap in at least
one exon and are transcribed in the same sense. The same criteria
are used when comparing RNA-Seq transcripts and known
annotations (Table 2).
Identification of coding potential
Putative coding capacity of novel transcripts was determined in
three complementary ways. First, we identified open reading frames
of 50 amino acids or longer. We next used the TranscriptDecoder
CanFam3.1 and Annotation
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package (http://sourceforge.net/p/transdecoder) - a collection of
scripts that identify open-read frames in nucleotide sequences and
compare them to the Pfam database of protein families, release 26
[48]. This rather stringent approach was complemented by a search
of translated nucleotide sequences against a set of vertebrate
proteins from RefSeq (downloaded in September 2012) using the
blastx algorithm from the Blast package (searching only the sense
strand, -S 1) [49]. Only Blast hits with a bitscore of over 60 were
included into our subsequent analyses in order to remove cases
where support for a possible homology in our opinion was too weak.
In total, we identified 3,455 hitherto unannotated loci that fall into
one of the categories above.
Expression atlas for canFam3.1
We determined a normalized expression estimate for all loci in
our expanded feature map and across our 19 (21 including
replicates for brain and kidney) samples using the cuffdiff tool from
the cufflinks package [24], correcting for sequencing biases (-b)
and multi-mapped reads (-u) and employing a upper quartile
normalization (-N).
Experimental verification of novel transcript expression
A tissue panel (brain, heart, kidney, liver, lung, pancreas, ovary,
skin, testis) was created from 23 samples donated from four
anonymous euthanized dogs. Total RNA was extracted from ,50
milligrams of tissue using the RNeasy mini kit (Qiagen) following
the manufacturers instruction and with an additional Turbo DNA-
free treatment (Ambion) to remove genomic DNA. RNA was
quantified on a Bioanalyser (RIN between 7 and 9 for all samples)
prior to cDNA synthesis using one microgram of total RNA and
the Advantage RT-for-PCR kit (Clontech). No gDNA contami-
nation was identified and so the expression of 22 novel loci were
measured and normalised against ACTB (primers, Table S7). Loci
were defined according to physical location, either intergenic or
antisense, and tissue specificity, where tissue specific loci were
required to be expressed at an FPKM.5.0 in a single tissue and
,2.0 in all others.
Cross species validation of novel transcripts
We identified a set of novel multi-exonic canine transcripts that
overlapped known genes in the antisense direction. Intron
spanning primers were designed to amplify products from dogs
and from orthologous human locations (Table S9). Intron
spanning primers for two proposed lincRNAs from the canine
transcriptome were designed to amplify products from canine,
mouse, and human kidney RNA (Table S9). To perform standard
RT-PCR, 2 ug each of canine kidney RNA (Zyagen, San Diego,
CA), mouse and human kidney RNA (Ambion, Austin, TX) were
treated with Turbo DNAse (Invitrogen) with subsequent cDNA
synthesis using Superscript II RT (Invitrogen). Specific PCR
products were then confirmed by Sanger sequencing.
Functional characterization of novel transcripts in murine
podocytes
To design shRNA constructs, multiple 21-mer targets were
identified for the murine BAIAP2 coding, BAIAP2 lincRNA, and
BAIAP2 antisense transcripts using the siRNA Selection Program
(http://jura.wi.mit.edu/bioc/siRNAext/); coding: GCAGCTG-
GCCTAGAACGTAAT, CTATTTCGATGCTCTGGTAAA;
lincRNA: GTAATTGACAAGTCCTTATTT, ACCATACCA-
TGCTGGTCTAAA, CACAGCTCCTTGTTGGCTTTC; anti-
sense: CCCAGTGACTTCAGACAACAT, GACTCAGCCAA-
TCACGGTTAA, AGGGAAGTTCTGAGATCCATC, CCAA-
GCCTCATGAACTCATTC.
Oligos were generated with the following sequence CCGG-
21 bp sense-CTCGAG-21 bp antisense-TTTTTG and subcloned
into the pLKO.1 plasmid (Addgene, Cambridge, MA). The
standard pLKO.1 scrambled plasmid was used as a control. All
plasmids were Sanger sequenced to verify correct subcloning. To
produce shRNA lentivirus, HEK 293-T cells grown in standard
growth media (DMEM, 10% FBS+pen/strep) were transfected
with each shRNA-pLKO.1 plasmid, along with the packaging
plasmid (delta R8.91, Addgene) and the envelope plasmid (VSVG,
Addgene) in a 10:10:1 ratio, respectively using Mirus LT
(Madison, WI) transfection reagent ((3:1 ratio plasmid DNA (ug)
to Mirus reagent (uL)). Virus containing media was collected after
72 hours, filtered, and frozen immediately in aliquots at 280
degrees. Conditionally immortalized murine podocytes [50] were
propagated under permissive conditions and seeded (56105) in 6
well plates. Upon reaching 90% confluence, the cells were
differentiated into podocytes (characterized by positive WT-1)
upon shifting to 37 degrees in the absence of gamma interferon.
The differentiated podocytes were infected with experiment
specific (scrambled, coding, lincRNA, anti sense) lentivirus six
days after thermoshift. For morphological analysis, podocytes were
seeded on coverslips and stained with a phalloidin actin stain
(Invitrogen, Carlsbad, CA) 4 days after infection. To perform the
migration assay, a single wound was performed in the center of
each well with a 200-ul pipette tip four days after infection.
Following three hours of serum starvation to synchronize the
podocytes, the cells were washed three times with PBS to remove
debris. Using a grid as a marker, images to assess cell migration
were obtained at 0, 24, 48 hours using a610 phase contrast
objective and the cells were fixed and stained with DAPI
(Invitrogen) at 48 hours. The number of cells that migrated into
the scratch (determined at T= 0) at 48 hours were recorded for
each experiment. The data for each condition represent the mean
+/2 SEM of six experiments. For quantitative PCR, RNA was
isolated from podocytes by RNeasy mini kit (Qiagen) and cDNA
synthesis was carried out via Superscript II RT (Invitrogen) using
standard conditions. Quantitative assays of BAIAP2 expression
(FP: cggctcacggaaaatgtcta, RP: gcgtctcttccaactggttc) were carried
out on a Light Cycler 480 (Roche) using Sybr Green Master Mix
(Roche) and HPRT (FP: ctggtgaaaaggacctctcgaa, RP: ctgaagtact-
cattatagtcaagggcat) as the internal control. Websites GAP4:
http://staden.sourceforge.net/manual/gap4_unix_2.html.
Primer3: http://bioinfo.ut.ee/primer3-0.4.0/primer3/.
Data access
The RNA Seq data is available in the short read archive under
NCBI BioProject PRJNA7882 and accessions SRX111061 -
SRX111071, SRX146606- SRX146608.
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